Home  |  Corporate Info  |  R & D  |  Products  |  Investor Relations  |  Careers at Hemispherx  


 

Hemispherx Biopharma Investor Relations

Welcome to Hemispherx Biopharma Investor Relations! In this section you can view the most recent Hemispherx press releases, SEC filings, including the 10K & 10Q, as well as obtain the contact information for the Company's Investor Relations contact, transfer agent and auditor. You may also request to receive news releases by e-mail.

Recent News:

 

8/27/2015 Hemispherx Biopharma Posts Photographs of the Ampligen Facility in New Brunswick, New Jersey

8/26/2015 Hemispherx Biopharma’s Judgment Unanimously Affirmed Against Cato Capital
Company to Update and Pursue Collection of at least $770,852.76 in Attorney Fees and Costs Awarded to it in Delaware Contract Dispute


8/26/2015 Hemispherx Biopharma Hosts Stockholder Open House at its Manufacturing and Research Development Center in New Jersey

8/19/2015 HEMISPHERX BIOPHARMA REMINDER REGARDING STOCKHOLDER OPEN HOUSE AT MANUFACTURING AND RESEARCH FACILITY IN NEW JERSEY

8/17/2015 Hemispherx Biopharma Extends its Strategic Alliance with Armada Health Care for Alferon N Injection®
….Two-year Extension Follows Completion of $8 million Upgrade and Preparation for Re-Launch of Alferon N in the US


More Releases...

Click Here for a complete archive

Transfer Agent

Continental Stock Transfer & Trust Company
Shareowner Services
2 Broadway
New York, New York 10004 
Tel: 212-509-4000
Fax: 212-509-5150

Independent Public Accountants

McGladrey & Pullen, LLP

 

Investor Relations:

Charles Jones
CJones & Associates Public Relations
888-557-6480
cjones@cjonespr.com